ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
apass
|
99 |
28K |
4 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
99
|
28K
|
4
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
apass
|
1.0K |
646K |
8 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
1.0K
|
646K
|
8
|
|
ASX - By Stock
|
DGR |
Re:
SolGold CEO leaves after less than a year in the top job
|
|
apass
|
73 |
19K |
5 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
73
|
19K
|
5
|
|
ASX - By Stock
|
WHC Coal |
Re:
Target $18.72
|
|
apass
|
9.5K |
4.2M |
6 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
9.5K
|
4.2M
|
6
|
|
ASX - By Stock
|
DGR |
Re:
News: DGR Uganda agrees oil exploration deals with two firms including Australia's DGR Global
|
|
apass
|
29 |
7.3K |
5 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
29
|
7.3K
|
5
|
|
ASX - By Stock
|
DGR |
Re:
Solgold Cornerstone Merger
|
|
apass
|
133 |
29K |
4 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
133
|
29K
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
apass
|
3.5K |
1.0M |
0 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
apass
|
5.9K |
2.3M |
12 |
19/08/22 |
19/08/22 |
Charts
|
5.9K
|
2.3M
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
apass
|
109 |
41K |
8 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
109
|
41K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
apass
|
109 |
41K |
15 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
109
|
41K
|
15
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
apass
|
109 |
41K |
2 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
109
|
41K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
apass
|
168 |
64K |
1 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
168
|
64K
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
apass
|
3.5K |
1.0M |
5 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
DGR |
Re:
SOLGOLD
|
|
apass
|
1.0K |
240K |
5 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
1.0K
|
240K
|
5
|
|
ASX - By Stock
|
DGR |
Re:
SOLGOLD
|
|
apass
|
1.0K |
240K |
6 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
1.0K
|
240K
|
6
|
|
ASX - By Stock
|
DGR |
Re:
Ann: Investor Update - Noosa Mining Conference
|
|
apass
|
30 |
7.4K |
6 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
30
|
7.4K
|
6
|
|
ASX - By Stock
|
DGR |
Re:
SOLGOLD
|
|
apass
|
1.0K |
240K |
6 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
1.0K
|
240K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Limb Girdle market as big as DMD
|
|
apass
|
4 |
1.3K |
2 |
16/07/22 |
16/07/22 |
ASX - By Stock
|
4
|
1.3K
|
2
|
|
ASX - By Stock
|
DGR |
Re:
Ann: Change in substantial holding for ANW
|
|
apass
|
4 |
1.1K |
5 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
4
|
1.1K
|
5
|
|
ASX - By Stock
|
DGR |
Re:
Atlantic Lithium Ann: Potential Takeover
|
|
apass
|
87 |
23K |
5 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
87
|
23K
|
5
|
|
Charts
|
PER |
Re:
Chart
|
|
apass
|
5.9K |
2.3M |
5 |
11/07/22 |
11/07/22 |
Charts
|
5.9K
|
2.3M
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
apass
|
3.5K |
1.0M |
2 |
09/07/22 |
09/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
apass
|
88 |
21K |
13 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
88
|
21K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
apass
|
88 |
21K |
4 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
88
|
21K
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
apass
|
3.5K |
1.0M |
4 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
SPR |
Re:
RMS still could bid for GCY
|
|
apass
|
74 |
25K |
2 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
74
|
25K
|
2
|
|
ASX - By Stock
|
DGR |
Re:
ALL
|
|
apass
|
359 |
72K |
7 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
359
|
72K
|
7
|
|
ASX - By Stock
|
JMS |
Re:
Global pivot towards cleaner, greener steel thrusts magnetite iron ore into spotlight
|
|
apass
|
15 |
11K |
10 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
15
|
11K
|
10
|
|
ASX - By Stock
|
JMS |
Re:
The time has come for Manganese!
|
|
apass
|
22 |
13K |
4 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
22
|
13K
|
4
|
|
ASX - By Stock
|
PER |
Re:
CR Shortfall
|
|
apass
|
99 |
30K |
4 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
99
|
30K
|
4
|
|
ASX - By Stock
|
NIC |
Re:
NPI Pricing dynamics for NIC
|
|
apass
|
81 |
33K |
2 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
81
|
33K
|
2
|
|
ASX - By Stock
|
NIC |
Re:
Nickel @ $35,000
|
|
apass
|
14 |
4.4K |
2 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
14
|
4.4K
|
2
|
|
ASX - By Stock
|
NIC |
Nickel @ $35,000
|
|
apass
|
14 |
4.4K |
1 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
14
|
4.4K
|
1
|
|
ASX - By Stock
|
NIC |
Re:
valuation and fundamentals
|
|
apass
|
36 |
16K |
3 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
36
|
16K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Change of Director's Interest Notice (MD)
|
|
apass
|
29 |
9.6K |
2 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
29
|
9.6K
|
2
|
|
ASX - By Stock
|
DGR |
Re:
Ann: Notice of Annual General Meeting
|
|
apass
|
34 |
6.8K |
7 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
34
|
6.8K
|
7
|
|
ASX - By Stock
|
DGR |
Re:
Ann: Notice of Annual General Meeting
|
|
apass
|
34 |
6.8K |
5 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
34
|
6.8K
|
5
|
|
ASX - By Stock
|
PER |
Re:
AGM on now
|
|
apass
|
78 |
22K |
7 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
78
|
22K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Update - Proposed issue of securities - ANP
|
|
apass
|
156 |
48K |
1 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
156
|
48K
|
1
|
|
ASX - By Stock
|
PER |
Re:
See How Wee Go
|
|
apass
|
62 |
18K |
11 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
62
|
18K
|
11
|
|
Charts
|
PER |
Re:
Chart
|
|
apass
|
5.9K |
2.3M |
1 |
27/10/21 |
27/10/21 |
Charts
|
5.9K
|
2.3M
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics appoints new Non-Executive Director
|
|
apass
|
34 |
10K |
1 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
34
|
10K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Pfizer takeover of CD47 blocking Co.
|
|
apass
|
41 |
13K |
0 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
41
|
13K
|
0
|
|
ASX - By Stock
|
DGR |
Re:
Ann: Successful Strategic Placement and Business Update
|
|
apass
|
58 |
11K |
10 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
58
|
11K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP and MCRI new R&D collaboration for ATL1102
|
|
apass
|
287 |
92K |
1 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
287
|
92K
|
1
|
|
ASX - By Stock
|
DGR |
Re:
Ann: Quarterly Activities Report
|
|
apass
|
6 |
1.9K |
3 |
26/06/21 |
26/06/21 |
ASX - By Stock
|
6
|
1.9K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US
|
|
apass
|
191 |
59K |
14 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
191
|
59K
|
14
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US
|
|
apass
|
191 |
59K |
10 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
191
|
59K
|
10
|
|
ASX - By Stock
|
LKO |
Re:
Ann: Half Yearly Report and Accounts
|
|
apass
|
13 |
7.3K |
1 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
13
|
7.3K
|
1
|
|
ASX - By Stock
|
DGR |
Re:
SOLGOLD
|
|
apass
|
1.0K |
240K |
2 |
10/05/21 |
10/05/21 |
ASX - By Stock
|
1.0K
|
240K
|
2
|
|